Reuters logo
BRIEF-Amicus Therapeutics announces approval for Galafold™ for treatment of Fabry disease in Canada
September 14, 2017 / 8:06 PM / in 3 months

BRIEF-Amicus Therapeutics announces approval for Galafold™ for treatment of Fabry disease in Canada

Sept 15 (Reuters) - Amicus Therapeutics Inc

* Amicus Therapeutics Inc announces approval for Galafold™ (Migalastat) for treatment of Fabry disease in Canada

* Amicus Therapeutics Inc - ‍Amicus expects to make Galafold available to Canadian patients in coming weeks​

* Amicus Therapeutics Inc says ‍following Health Canada approval, Amicus expects to make Galafold available to Canadian patients in coming weeks​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below